Mupirocin Calcium Patent Expiration
Mupirocin Calcium is Used for treating nasal passage infections and secondary infections of skin lesions caused by Methicillin-resistant S. aureus and S. pyogenes. It was first introduced by Glaxosmithkline
Mupirocin Calcium Patents
Given below is the list of patents protecting Mupirocin Calcium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Bactroban | US6025389 | Pharmaceutical and veterinary compositions of mupirocin and methods for their preparation |
Oct 20, 2014
(Expired) | Glaxosmithkline |
| Bactroban | US5569672 | Compounds |
Oct 29, 2013
(Expired) | Glaxosmithkline |
Mupirocin Calcium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List